SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-099726 from Athena Technology Acquisition Corp. II (ATEK, ATEKW) (CIK 0001882198) (ATEK)

Athena Technology Acquisition Corp. II (ATEK, ATEKW) (CIK 0001882198)
Date: Nov. 18, 2024 · CIK: 0001882198 · Accession: 0001213900-24-099726

AI Filing Summary & Sentiment

File numbers found in text: 001-41144

Referenced dates: November 15, 2024

Date
November 18, 2024
Author
Peyton Worley
Form
CORRESP
Company
Athena Technology Acquisition Corp. II (ATEK, ATEKW) (CIK 0001882198)

Letter

330 North Wabash Avenue

Suite 2800

Chicago, Illinois 60611

330 North Wabash Avenue

Tel: +1.312.876.7700 Fax: +1.312.993.9767

www.lw.com

FIRM / AFFILIATE OFFICES

Austin Milan

Beijing Munich

Boston New York

Brussels Orange County

Century City Paris

Chicago Riyadh

November 18, 2024

Dubai San Diego

Düsseldorf San Francisco

VIA EDGAR

Frankfurt Seoul

Hamburg Silicon Valley

United States Securities and Exchange Commission

Hong Kong Singapore

Division of Corporation Finance

Houston Tel Aviv

Office of Trade & Services

London Tokyo

100 F Street, N.E.

Los Angeles Washington, D.C.

Washington, D.C. 20549-6010

Madrid

Attention: Pearlyne Paulemon, Brigitte Lippmann

Re: Athena Technology Acquisition Corp. II

Preliminary Proxy Statement on Schedule 14A

Filed November 4, 2024

File No. 001-41144

Ladies and Gentlemen:

On behalf of our client, Athena Technology Acquisition Corp. II (the “Company”), set forth below is the Company’s response to the comment of the staff (the “Staff”) of the Securities and Exchange Commission in their letter dated November 15, 2024 relating to the Company’s Preliminary Proxy Statement on Schedule 14A filed on November 4, 2024 (the “Proxy Statement”). Concurrently with the submission of this letter, the Company has publicly filed Amendment No. 1 on Schedule 14A (“Amendment No. 1”), which reflects the revisions described herein and certain other updated information.

For ease of reference, the text of the comment in the Staff’s letter has been reproduced in italics herein, with the Company’s response immediately following. Unless otherwise indicated, capitalized terms used herein have the meanings assigned to them in Amendment No. 1.

Preliminary Proxy Statement on Schedule 14A

Risk Factors, page 22

1. We note that you are seeking to extend your termination date to September 14, 2025, a date which is 45 months from your initial public offering. We also note that you are currently listed on the NYSE American and Section 119(b) of the NYSE American Company Guide requires that a special purpose acquisition company complete a business combination within 36 months of the effectiveness of its IPO registration statement. Please revise your disclosure regarding a right to appeal a delisting to conform with your language on page 23 that states that your securities will face immediate suspension and delisting action once you receive a delisting determination letter from the NYSE American after the 36-month window ends on December 10, 2024. See Section 119(f) of the NYSE American Company Guide. In addition, disclose that as a consequence of any such suspension or delisting, you may no longer be attractive as a merger partner.

Response: In response to the Staff’s comment, the Company respectfully advises the Staff that it has revised the disclosure on page 23 of Amendment No. 1 to reflect that the NYSE American suspension and delisting action are subject to an appeal pursuant to Part 12 of the NYSE American Company Guide. Further, the Company has revised the disclosure on pages 22 and 23 of Amendment No. 1 to note that any such suspension or delisting may cause the Company to be unable to attract a merger partner.

* * *

November 18, 2024

Page 2

Should you have any comments or questions regarding the foregoing, please call me at (312) 876-7605 or e-mail me at scott.westhoff@lw.com, or Peyton Worley at (212) 906-1282 or peyton.worley@lw.com. Thank you in advance for your attention to this matter.

Very truly yours,
cc:
Peyton Worley,
Latham & Watkins LLP

Show Raw Text
CORRESP
1
filename1.htm

    330 North Wabash Avenue

    Suite 2800

    Chicago, Illinois 60611

    330 North Wabash Avenue

    Tel: +1.312.876.7700 Fax: +1.312.993.9767

    www.lw.com

    FIRM / AFFILIATE OFFICES

    Austin
    Milan

    Beijing
    Munich

    Boston
    New York

    Brussels
    Orange County

    Century City
    Paris

    Chicago
    Riyadh

    November 18, 2024

    Dubai
    San Diego

    Düsseldorf
    San Francisco

    VIA EDGAR

    Frankfurt
    Seoul

    Hamburg
    Silicon Valley

    United States Securities and Exchange Commission

    Hong Kong
    Singapore

    Division of Corporation Finance

    Houston
    Tel Aviv

    Office of Trade & Services

    London
    Tokyo

    100 F Street, N.E.

    Los Angeles
    Washington, D.C.

    Washington, D.C. 20549-6010

    Madrid

    Attention:
    Pearlyne Paulemon, Brigitte Lippmann

    Re:
    Athena Technology Acquisition
    Corp. II

    Preliminary Proxy Statement on
    Schedule 14A

    Filed November 4, 2024

    File No. 001-41144

Ladies
and Gentlemen:

On
behalf of our client, Athena Technology Acquisition Corp. II (the “Company”), set forth below is the Company’s
response to the comment of the staff (the “Staff”) of the Securities and Exchange Commission in their letter dated
November 15, 2024 relating to the Company’s Preliminary Proxy Statement on Schedule 14A filed on November 4, 2024 (the “Proxy
Statement”). Concurrently with the submission of this letter, the Company has publicly filed Amendment No. 1 on Schedule 14A
(“Amendment No. 1”), which reflects the revisions described herein and certain other updated information.

For
ease of reference, the text of the comment in the Staff’s letter has been reproduced in italics herein, with the Company’s
response immediately following. Unless otherwise indicated, capitalized terms used herein have the meanings assigned to them in Amendment
No. 1.

Preliminary
Proxy Statement on Schedule 14A

Risk Factors,
page 22

 1. We
                                            note that you are seeking to extend your termination date to September 14, 2025, a date which
                                            is 45 months from your initial public offering. We also note that you are currently listed
                                            on the NYSE American and Section 119(b) of the NYSE American Company Guide requires that
                                            a special purpose acquisition company complete a business combination within 36 months of
                                            the effectiveness of its IPO registration statement. Please revise your disclosure regarding
                                            a right to appeal a delisting to conform with your language on page 23 that states that your
                                            securities will face immediate suspension and delisting action once you receive a delisting
                                            determination letter from the NYSE American after the 36-month window ends on December 10,
                                            2024. See Section 119(f) of the NYSE American Company Guide. In addition, disclose that as
                                            a consequence of any such suspension or delisting, you may no longer be attractive as a merger
                                            partner.

Response:
In response to the Staff’s comment, the Company respectfully advises the Staff that it has revised the disclosure on page 23 of
Amendment No. 1 to reflect that the NYSE American suspension and delisting action are subject to an appeal pursuant to Part 12 of the
NYSE American Company Guide. Further, the Company has revised the disclosure on pages 22 and 23 of Amendment No. 1 to note that any such
suspension or delisting may cause the Company to be unable to attract a merger partner.

*     *     *

November
18, 2024

Page 2

Should
you have any comments or questions regarding the foregoing, please call me at (312) 876-7605 or e-mail me at scott.westhoff@lw.com, or
Peyton Worley at (212) 906-1282 or peyton.worley@lw.com. Thank you in advance for your attention to this matter.

    Very truly yours,

    cc:
    Peyton Worley,
    Latham & Watkins LLP

    /s/
    Scott W. Westhoff

    Scott
    W. Westhoff

    of
    LATHAM & WATKINS LLP